Filing Details
- Accession Number:
- 0001477449-25-000016
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-04 16:06:13
- Reporting Period:
- 2025-02-28
- Filing Date:
- 2025-03-04
- Accepted Time:
- 2025-03-04 16:06:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1477449 | Teladoc Health Inc. | TDOC | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1375088 | C Adam Vandervoort | C/O Teladoc Health, Inc., 2 Manhattanville Road, Suite 203 Purchase NY 10577 | Chief Legal Officer, Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-02-28 | 1,881 | $0.00 | 51,931 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2025-03-28 | 4,418 | $0.00 | 56,349 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2025-02-28 | 1,505 | $0.00 | 57,854 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-03-03 | 3,935 | $9.68 | 53,919 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2025-02-28 | 1,881 | $0.00 | 1,881 | $0.00 |
| Common Stock | Restricted Stock Units | Disposition | 2025-02-28 | 4,418 | $0.00 | 4,418 | $0.00 |
| Common Stock | Performance Stock Units | Disposition | 2025-02-28 | 1,505 | $0.00 | 1,505 | $0.00 |
| Common Stock | Restricted Stock Units | Acquisiton | 2025-03-01 | 109,832 | $0.00 | 109,832 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | M | Direct | ||
| 17,672 | No | 4 | M | Direct | ||
| 6,025 | No | 4 | M | Direct | ||
| 109,832 | No | 4 | A | Direct |
Footnotes
- Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
- Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
- Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
- On March 1, 2022, the reporting person was granted 22,571 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- On March 3, 2023, the reporting person was granted 53,013 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- On March 1, 2024, the reporting person earned 18,067 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- Each restricted stock unit represents a contingent right to receive one share of TDOC common stock
- One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
Billionaire Hedge Funds
